F R Matthias|F Liemann - JoVE Visualize

Showing results (21-30 of 27) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 27 results.

Thrombosis Research|May 1, 1987

Increase in the degree of phosphorylation of circulating fibrinogen under thrombolytic therapy with urokinaseH H Seydewitz, F R Matthias, T H Schöndorf, et al.

Thrombosis and Haemostasis|April 30, 1976

Studies on chemically modified fibrinogenM Kloczewiak, Z Wegrzynowicz, F R Matthias, et al.

Klinische Wochenschrift|June 1, 1977

[Dysfibrinogenemia. A new case: dysfibrinogenemia Giessen III (author's transl)]F R Matthias, W H Krause, S Ganssert, et al.

Zeitschrift Fur Kardiologie|January 24, 2004

[Persistent angina pectoris in spite of successful myocardial revascularisation]O Kohl, M Grebe, H Hölschermann, et al.

Medizinische Klinik (Munich, Germany : 1983)|November 15, 1996

[Coronary risk factors in chronic hemodialysis patients]F Lübbecke, F R Matthias, U Richter, et al.

Thrombosis Research|November 15, 1983

Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparinH Ditter, D Heinrich, F R Matthias, et al.

Intensive Care Medicine|August 29, 1998

Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsisB Eisele, M Lamy, L G Thijs, et al.

Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 27 results.

Thrombosis Research|May 1, 1987

Increase in the degree of phosphorylation of circulating fibrinogen under thrombolytic therapy with urokinaseH H Seydewitz, F R Matthias, T H Schöndorf, et al.

Thrombosis and Haemostasis|April 30, 1976

Studies on chemically modified fibrinogenM Kloczewiak, Z Wegrzynowicz, F R Matthias, et al.

Klinische Wochenschrift|June 1, 1977

[Dysfibrinogenemia. A new case: dysfibrinogenemia Giessen III (author's transl)]F R Matthias, W H Krause, S Ganssert, et al.

Zeitschrift Fur Kardiologie|January 24, 2004

[Persistent angina pectoris in spite of successful myocardial revascularisation]O Kohl, M Grebe, H Hölschermann, et al.

Medizinische Klinik (Munich, Germany : 1983)|November 15, 1996

[Coronary risk factors in chronic hemodialysis patients]F Lübbecke, F R Matthias, U Richter, et al.

Thrombosis Research|November 15, 1983

Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparinH Ditter, D Heinrich, F R Matthias, et al.

Intensive Care Medicine|August 29, 1998

Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsisB Eisele, M Lamy, L G Thijs, et al.

Pageof 3